Hamim Zahir

7PUBLICATIONS
3CO-AUTHORS
PharmacogenomicsInfant and child healthToxicology (incl. clinical toxicology)Biomolecular modelling and designMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 02, 2024
Understanding the mechanisms of food effect on omaveloxolone pharmacokinetics through physiologically based biopharmaceutics modeling.

Xavier J H Pepin, Scott M Hynes, Hamim Zahir

|Feb 18, 2024
Pharmacokinetics, Pharmacodynamics, and Safety of Edoxaban in Pediatric Subjects: A Phase I Single-Dose Study.

Peng Zou, Hamim Zahir, Anil Duggal

|May 07, 2019
Abuse potential of mirogabalin in recreational polydrug users.

Jeanne Mendell, Naama Levy-Cooperman, Ed Sellers

|Sep 02, 2018
Open-Label Single-Dose Study to Assess the Effect of Mild and Moderate Hepatic Impairment on the Pharmacokinetics of Mirogabalin.

Kenneth Duchin, Giorgio Senaldi, Vance Warren

|Aug 29, 2018
Tolerability, pharmacokinetics, and pharmacodynamics of mirogabalin in healthy subjects: Results from phase 1 studies.

Karen Brown, Jeanne Mendell, Shoichi Ohwada

|Jun 20, 2018
Coadministration of probenecid and cimetidine with mirogabalin in healthy subjects: A phase 1, randomized, open-label, drug-drug interaction study.

Masaya Tachibana, Naotoshi Yamamura, George J Atiee

Pageof 2